Alan Moses
Angel
Board director at 2 startups that filed Form D raises since late 2024.
- Stages
- Seed, Series A
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Aug 2024
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: BiomXMar 3, 2023
- SEC Form D: Chemomab TherapeuticsAug 9, 2024
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.